

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.50368945 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.87337996 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.87337996 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.79807073 |
| 5 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.78381137 |
| 6 | postsynaptic membrane organization (GO:0001941) | 4.58637868 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.40379854 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.33936374 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.29601036 |
| 10 | vocalization behavior (GO:0071625) | 4.26807728 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.10812195 |
| 12 | protein localization to endosome (GO:0036010) | 4.07765505 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.03905951 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.01630499 |
| 15 | locomotory exploration behavior (GO:0035641) | 3.86826491 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.84625686 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.84438528 |
| 18 | glutamate secretion (GO:0014047) | 3.81944260 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.81221899 |
| 20 | positive regulation of synapse maturation (GO:0090129) | 3.81064037 |
| 21 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.78877684 |
| 22 | semaphorin-plexin signaling pathway (GO:0071526) | 3.77682423 |
| 23 | cell communication by electrical coupling (GO:0010644) | 3.66430331 |
| 24 | protein localization to synapse (GO:0035418) | 3.64182887 |
| 25 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.64089502 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.59391348 |
| 27 | adherens junction assembly (GO:0034333) | 3.59373021 |
| 28 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.57501313 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.52806178 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.52566241 |
| 31 | response to pheromone (GO:0019236) | 3.52430606 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50622117 |
| 33 | negative regulation of cell size (GO:0045792) | 3.50538053 |
| 34 | mannose metabolic process (GO:0006013) | 3.46671944 |
| 35 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.45837232 |
| 36 | cell-substrate adherens junction assembly (GO:0007045) | 3.40574802 |
| 37 | focal adhesion assembly (GO:0048041) | 3.40574802 |
| 38 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.40434267 |
| 39 | presynaptic membrane assembly (GO:0097105) | 3.39319137 |
| 40 | barbed-end actin filament capping (GO:0051016) | 3.38522380 |
| 41 | neurotransmitter secretion (GO:0007269) | 3.35978289 |
| 42 | cerebellar granule cell differentiation (GO:0021707) | 3.33930236 |
| 43 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32275865 |
| 44 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.31132071 |
| 45 | cell-substrate junction assembly (GO:0007044) | 3.27765150 |
| 46 | basement membrane organization (GO:0071711) | 3.27456627 |
| 47 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.24333884 |
| 48 | striatum development (GO:0021756) | 3.22897025 |
| 49 | regulation of extracellular matrix disassembly (GO:0010715) | 3.19047461 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.17604658 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16471436 |
| 52 | sodium ion export (GO:0071436) | 3.16207562 |
| 53 | auditory behavior (GO:0031223) | 3.14721056 |
| 54 | skin morphogenesis (GO:0043589) | 3.08922207 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.08565709 |
| 56 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.03125768 |
| 57 | stress fiber assembly (GO:0043149) | 3.00629292 |
| 58 | urinary tract smooth muscle contraction (GO:0014848) | 3.00253969 |
| 59 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.00122434 |
| 60 | negative regulation of fatty acid transport (GO:2000192) | 2.99325356 |
| 61 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.99156308 |
| 62 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.98286104 |
| 63 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.98065001 |
| 64 | regulation of synapse maturation (GO:0090128) | 2.97221513 |
| 65 | exploration behavior (GO:0035640) | 2.97132080 |
| 66 | presynaptic membrane organization (GO:0097090) | 2.95455280 |
| 67 | long-term synaptic potentiation (GO:0060291) | 2.94622199 |
| 68 | NADH metabolic process (GO:0006734) | 2.92996886 |
| 69 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.92492470 |
| 70 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.92358009 |
| 71 | cell migration in hindbrain (GO:0021535) | 2.90169279 |
| 72 | synapse assembly (GO:0007416) | 2.86686656 |
| 73 | response to auditory stimulus (GO:0010996) | 2.85507871 |
| 74 | membrane depolarization during action potential (GO:0086010) | 2.84596988 |
| 75 | activation of protein kinase A activity (GO:0034199) | 2.84540950 |
| 76 | female mating behavior (GO:0060180) | 2.84178865 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.83499995 |
| 78 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.83499995 |
| 79 | oxaloacetate metabolic process (GO:0006107) | 2.83186278 |
| 80 | cerebellar Purkinje cell layer development (GO:0021680) | 2.82322449 |
| 81 | epithelial cell-cell adhesion (GO:0090136) | 2.80762662 |
| 82 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.79112095 |
| 83 | neuronal action potential propagation (GO:0019227) | 2.78613591 |
| 84 | innervation (GO:0060384) | 2.77431541 |
| 85 | mechanosensory behavior (GO:0007638) | 2.75562980 |
| 86 | inositol phosphate catabolic process (GO:0071545) | 2.74340820 |
| 87 | embryonic process involved in female pregnancy (GO:0060136) | 2.73809096 |
| 88 | cell-cell junction maintenance (GO:0045217) | 2.72792492 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 2.72100852 |
| 90 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.71965277 |
| 91 | proline transport (GO:0015824) | 2.71193507 |
| 92 | cellular potassium ion homeostasis (GO:0030007) | 2.70965646 |
| 93 | activation of Rac GTPase activity (GO:0032863) | 2.69853474 |
| 94 | regulation of neurotransmitter secretion (GO:0046928) | 2.68687552 |
| 95 | regulation of female receptivity (GO:0045924) | 2.67720400 |
| 96 | positive regulation of membrane potential (GO:0045838) | 2.67716152 |
| 97 | tricarboxylic acid cycle (GO:0006099) | 2.67092898 |
| 98 | regulation of beta-amyloid formation (GO:1902003) | 2.66909846 |
| 99 | neurotransmitter transport (GO:0006836) | 2.66098917 |
| 100 | hemidesmosome assembly (GO:0031581) | 2.66077672 |
| 101 | negative regulation of microtubule polymerization (GO:0031115) | 2.65771590 |
| 102 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.65694178 |
| 103 | regulation of ARF protein signal transduction (GO:0032012) | 2.65685175 |
| 104 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.65278438 |
| 105 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.64828098 |
| 106 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.63726189 |
| 107 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63528615 |
| 108 | transferrin transport (GO:0033572) | 2.62401353 |
| 109 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.62197570 |
| 110 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.62165598 |
| 111 | response to laminar fluid shear stress (GO:0034616) | 2.61100859 |
| 112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.60791421 |
| 113 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.60419275 |
| 114 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.59222908 |
| 115 | neuromuscular synaptic transmission (GO:0007274) | 2.58728745 |
| 116 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.58144393 |
| 117 | maternal placenta development (GO:0001893) | 2.57438347 |
| 118 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.57302390 |
| 119 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57024195 |
| 120 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.56708522 |
| 121 | vesicle coating (GO:0006901) | 2.56519160 |
| 122 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.56428829 |
| 123 | positive regulation of receptor recycling (GO:0001921) | 2.56087616 |
| 124 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.56072070 |
| 125 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.55828899 |
| 126 | protein targeting to plasma membrane (GO:0072661) | 2.55296959 |
| 127 | regulation of neurotransmitter transport (GO:0051588) | 2.53980134 |
| 128 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.53257719 |
| 129 | synapse organization (GO:0050808) | 2.52984562 |
| 130 | regulation of membrane repolarization (GO:0060306) | 2.52885764 |
| 131 | cell communication involved in cardiac conduction (GO:0086065) | 2.52463325 |
| 132 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.52461809 |
| 133 | glutamate receptor signaling pathway (GO:0007215) | 2.52265497 |
| 134 | gonadal mesoderm development (GO:0007506) | 2.51821341 |
| 135 | establishment of synaptic vesicle localization (GO:0097480) | 2.51459821 |
| 136 | synaptic vesicle transport (GO:0048489) | 2.51459821 |
| 137 | regulation of cholesterol homeostasis (GO:2000188) | 2.51239206 |
| 138 | regulation of cell communication by electrical coupling (GO:0010649) | 2.50758329 |
| 139 | succinate metabolic process (GO:0006105) | 2.50541487 |
| 140 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.50250744 |
| 141 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.49834377 |
| 142 | apoptotic process involved in morphogenesis (GO:0060561) | 2.49765506 |
| 143 | positive regulation of synapse assembly (GO:0051965) | 2.49553654 |
| 144 | positive regulation of synaptic transmission (GO:0050806) | 2.48814054 |
| 145 | dendrite morphogenesis (GO:0048813) | 2.48610253 |
| 146 | positive regulation of nuclease activity (GO:0032075) | 2.48311529 |
| 147 | glycogen catabolic process (GO:0005980) | 2.47206240 |
| 148 | cortical actin cytoskeleton organization (GO:0030866) | 2.46715734 |
| 149 | dopamine receptor signaling pathway (GO:0007212) | 2.45835609 |
| 150 | endothelial cell chemotaxis (GO:0035767) | 2.42154757 |
| 151 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.41636885 |
| 152 | regulation of ARF GTPase activity (GO:0032312) | 2.37249143 |
| 153 | retrograde transport, endosome to Golgi (GO:0042147) | 2.36594819 |
| 154 | cellular response to prostaglandin stimulus (GO:0071379) | 2.35348356 |
| 155 | actin filament depolymerization (GO:0030042) | 2.32964427 |
| 156 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.29736783 |
| 157 | pinocytosis (GO:0006907) | 2.29540513 |
| 158 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27966763 |
| 159 | regulation of early endosome to late endosome transport (GO:2000641) | 2.27288148 |
| 160 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.27194204 |
| 161 | apoptotic cell clearance (GO:0043277) | 2.26386050 |
| 162 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.26064447 |
| 163 | actin filament bundle organization (GO:0061572) | 2.23820881 |
| 164 | actin filament bundle assembly (GO:0051017) | 2.23820881 |
| 165 | regulation of extracellular matrix organization (GO:1903053) | 2.23658678 |
| 166 | layer formation in cerebral cortex (GO:0021819) | 2.23402404 |
| 167 | cortical cytoskeleton organization (GO:0030865) | 2.23326364 |
| 168 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.23237189 |
| 169 | stress granule assembly (GO:0034063) | 2.23061155 |
| 170 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.22555393 |
| 171 | regulation of establishment of planar polarity (GO:0090175) | 2.21695635 |
| 172 | cell adhesion mediated by integrin (GO:0033627) | 2.21104153 |
| 173 | histone H4 deacetylation (GO:0070933) | 2.19355468 |
| 174 | cell volume homeostasis (GO:0006884) | 2.19164037 |
| 175 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.18653511 |
| 176 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.18120265 |
| 177 | alpha-linolenic acid metabolic process (GO:0036109) | 2.18062318 |
| 178 | desmosome organization (GO:0002934) | 2.17632609 |
| 179 | atrioventricular valve morphogenesis (GO:0003181) | 2.17125284 |
| 180 | modulation by virus of host morphology or physiology (GO:0019048) | 2.16279815 |
| 181 | regulation of nuclease activity (GO:0032069) | 2.16205310 |
| 182 | UV protection (GO:0009650) | 2.15268907 |
| 183 | membrane protein ectodomain proteolysis (GO:0006509) | 2.13867606 |
| 184 | negative regulation of myotube differentiation (GO:0010832) | 2.13795852 |
| 185 | adherens junction organization (GO:0034332) | 2.12969448 |
| 186 | ER-nucleus signaling pathway (GO:0006984) | 2.12403997 |
| 187 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.12022364 |
| 188 | protein heterotrimerization (GO:0070208) | 2.11820471 |
| 189 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.11463350 |
| 190 | negative regulation of catenin import into nucleus (GO:0035414) | 2.10872692 |
| 191 | proline biosynthetic process (GO:0006561) | 2.10699948 |
| 192 | eye morphogenesis (GO:0048592) | 2.08722828 |
| 193 | endodermal cell differentiation (GO:0035987) | 2.08353535 |
| 194 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.07783410 |
| 195 | peptidyl-proline hydroxylation (GO:0019511) | 2.07615733 |
| 196 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.07599736 |
| 197 | activation of JUN kinase activity (GO:0007257) | 2.06740130 |
| 198 | embryo implantation (GO:0007566) | 2.06043413 |
| 199 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.05888751 |
| 200 | convergent extension (GO:0060026) | 2.04537192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.04833761 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.74409322 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.31935755 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00842704 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.91606912 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.89846896 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76033893 |
| 8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.63777445 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63276807 |
| 10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.62665302 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49336421 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.45919784 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44972932 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.44389559 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43948704 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43832453 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.43381448 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.40531273 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36345214 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34063062 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.33808365 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.33673883 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31308345 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29864786 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29864786 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.26065272 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25785041 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24154399 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22955262 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21559598 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.20405694 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 2.16502819 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15952947 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.12760806 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.12752046 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11679371 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 2.11173168 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05236106 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01372914 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98819919 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97306755 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96010898 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95985890 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.89395780 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85019007 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.83178833 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.82096631 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74603217 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74129555 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73164210 |
| 51 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.70211640 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68411065 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65279103 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61094481 |
| 55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.60928653 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59697284 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59647554 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58341643 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.58247892 |
| 60 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.57371228 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55568230 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.55486110 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54816642 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54669885 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52167414 |
| 66 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.51009888 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49927288 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.46743835 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46469115 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43949023 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43761087 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43500790 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43089231 |
| 74 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.41892071 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40082735 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39045401 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37027820 |
| 78 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36995910 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.36565663 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33975552 |
| 81 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33135867 |
| 82 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.31803606 |
| 83 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29664062 |
| 84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28470769 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28130884 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.28063445 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.27731750 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26015449 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25796163 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25577102 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23031519 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22130018 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21719695 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21424325 |
| 95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21186999 |
| 96 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19104908 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19076732 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18471954 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18177418 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16821710 |
| 101 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16654488 |
| 102 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16504006 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16382655 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16074094 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16005162 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14955724 |
| 107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14925634 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14096043 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14032110 |
| 110 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13083369 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12803517 |
| 112 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.12667051 |
| 113 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12135049 |
| 114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12014390 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12014390 |
| 116 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11233279 |
| 117 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11023432 |
| 118 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10014272 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09961456 |
| 120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09444556 |
| 121 | MAF_26560356_Chip-Seq_TH1_Human | 1.07904849 |
| 122 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07203050 |
| 123 | AR_19668381_ChIP-Seq_PC3_Human | 1.06657292 |
| 124 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06479063 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05642292 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05417957 |
| 127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04850237 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04770091 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04712244 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04697615 |
| 131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.04012377 |
| 132 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.03958918 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03180574 |
| 134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02132436 |
| 135 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01659604 |
| 136 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01476965 |
| 137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99414524 |
| 138 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99101797 |
| 139 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98539514 |
| 140 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98372976 |
| 141 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98219157 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97994956 |
| 143 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97632555 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97588773 |
| 145 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97447101 |
| 146 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97312803 |
| 147 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97312803 |
| 148 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97191114 |
| 149 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96874352 |
| 150 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96230655 |
| 151 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95806012 |
| 152 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95199188 |
| 153 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95164191 |
| 154 | MAF_26560356_Chip-Seq_TH2_Human | 0.95124666 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95015857 |
| 156 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92894587 |
| 157 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92102637 |
| 158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92027696 |
| 159 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91035488 |
| 160 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.88974894 |
| 161 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88714404 |
| 162 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88432191 |
| 163 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87532426 |
| 164 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86904212 |
| 165 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86889934 |
| 166 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86447357 |
| 167 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.86057509 |
| 168 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86035931 |
| 169 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85353191 |
| 170 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85100163 |
| 171 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.84421278 |
| 172 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84162744 |
| 173 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83760070 |
| 174 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81952784 |
| 175 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.80782260 |
| 176 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80031155 |
| 177 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78283188 |
| 178 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78010020 |
| 179 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.77702269 |
| 180 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.77222794 |
| 181 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.76898822 |
| 182 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76681115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.88001401 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.16830398 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.82355660 |
| 4 | MP0003880_abnormal_central_pattern | 3.38176358 |
| 5 | MP0003566_abnormal_cell_adhesion | 3.23264987 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.11705135 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.83125272 |
| 8 | MP0002736_abnormal_nociception_after | 2.69631047 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.64756750 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.64217103 |
| 11 | MP0002822_catalepsy | 2.63788345 |
| 12 | MP0001849_ear_inflammation | 2.61629946 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.60413920 |
| 14 | MP0000751_myopathy | 2.56718570 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.56546179 |
| 16 | MP0001958_emphysema | 2.53307510 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.49480462 |
| 18 | MP0000013_abnormal_adipose_tissue | 2.47235546 |
| 19 | MP0009745_abnormal_behavioral_response | 2.43253071 |
| 20 | MP0004270_analgesia | 2.42409086 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.39829523 |
| 22 | MP0004858_abnormal_nervous_system | 2.36321362 |
| 23 | MP0004272_abnormal_basement_membrane | 2.32509744 |
| 24 | MP0002064_seizures | 2.31466376 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.31100197 |
| 26 | MP0005076_abnormal_cell_differentiation | 2.27122195 |
| 27 | MP0003091_abnormal_cell_migration | 2.26362481 |
| 28 | MP0008260_abnormal_autophagy | 2.22960989 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 2.22111537 |
| 30 | MP0001984_abnormal_olfaction | 2.19719153 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 2.11324438 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 2.10475695 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 2.08252467 |
| 34 | MP0002735_abnormal_chemical_nociception | 2.07062573 |
| 35 | MP0006276_abnormal_autonomic_nervous | 2.06880743 |
| 36 | MP0003279_aneurysm | 2.05315075 |
| 37 | MP0002909_abnormal_adrenal_gland | 2.01340224 |
| 38 | MP0008569_lethality_at_weaning | 1.89191534 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.89159492 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.88430164 |
| 41 | MP0003329_amyloid_beta_deposits | 1.87132363 |
| 42 | MP0009046_muscle_twitch | 1.85482910 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.85238655 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.83415858 |
| 45 | MP0003122_maternal_imprinting | 1.81535329 |
| 46 | MP0000537_abnormal_urethra_morphology | 1.81079072 |
| 47 | MP0002272_abnormal_nervous_system | 1.81067813 |
| 48 | MP0005451_abnormal_body_composition | 1.75926460 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.75394700 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.69223596 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.67409550 |
| 52 | MP0005275_abnormal_skin_tensile | 1.67195169 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.63601311 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.62377102 |
| 55 | MP0001970_abnormal_pain_threshold | 1.60660658 |
| 56 | MP0001486_abnormal_startle_reflex | 1.58751154 |
| 57 | MP0000733_abnormal_muscle_development | 1.57776573 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.57678569 |
| 59 | MP0002184_abnormal_innervation | 1.57205311 |
| 60 | MP0000749_muscle_degeneration | 1.53849197 |
| 61 | MP0009840_abnormal_foam_cell | 1.52909307 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.51902357 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.50869916 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.50814938 |
| 65 | MP0005623_abnormal_meninges_morphology | 1.49322476 |
| 66 | MP0003646_muscle_fatigue | 1.44224816 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 1.43871540 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.42965002 |
| 69 | MP0001440_abnormal_grooming_behavior | 1.42216283 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.40125267 |
| 71 | MP0003787_abnormal_imprinting | 1.39490173 |
| 72 | MP0004264_abnormal_extraembryonic_tissu | 1.37826066 |
| 73 | MP0004233_abnormal_muscle_weight | 1.35193848 |
| 74 | MP0004130_abnormal_muscle_cell | 1.35051033 |
| 75 | MP0005503_abnormal_tendon_morphology | 1.34528749 |
| 76 | MP0001188_hyperpigmentation | 1.34332964 |
| 77 | MP0005023_abnormal_wound_healing | 1.33802179 |
| 78 | MP0003879_abnormal_hair_cell | 1.30732044 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.30625025 |
| 80 | MP0002060_abnormal_skin_morphology | 1.29855890 |
| 81 | MP0001501_abnormal_sleep_pattern | 1.27515218 |
| 82 | MP0002896_abnormal_bone_mineralization | 1.27000432 |
| 83 | MP0010368_abnormal_lymphatic_system | 1.26766936 |
| 84 | MP0000858_altered_metastatic_potential | 1.26080039 |
| 85 | MP0003115_abnormal_respiratory_system | 1.24746496 |
| 86 | MP0010386_abnormal_urinary_bladder | 1.23299989 |
| 87 | MP0001915_intracranial_hemorrhage | 1.23251451 |
| 88 | MP0005375_adipose_tissue_phenotype | 1.22679770 |
| 89 | MP0000955_abnormal_spinal_cord | 1.20997114 |
| 90 | MP0004084_abnormal_cardiac_muscle | 1.20147459 |
| 91 | MP0002089_abnormal_postnatal_growth/wei | 1.19046011 |
| 92 | MP0005666_abnormal_adipose_tissue | 1.17870372 |
| 93 | MP0002882_abnormal_neuron_morphology | 1.17511244 |
| 94 | MP0004085_abnormal_heartbeat | 1.16972788 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 1.16963577 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 1.16152067 |
| 97 | MP0003436_decreased_susceptibility_to | 1.10930657 |
| 98 | MP0009278_abnormal_bone_marrow | 1.10121576 |
| 99 | MP0000778_abnormal_nervous_system | 1.09992703 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 1.09633024 |
| 101 | MP0004924_abnormal_behavior | 1.08445870 |
| 102 | MP0005386_behavior/neurological_phenoty | 1.08445870 |
| 103 | MP0002249_abnormal_larynx_morphology | 1.08343752 |
| 104 | MP0004215_abnormal_myocardial_fiber | 1.05758350 |
| 105 | MP0003385_abnormal_body_wall | 1.04780186 |
| 106 | MP0003942_abnormal_urinary_system | 1.04130053 |
| 107 | MP0000003_abnormal_adipose_tissue | 1.03314007 |
| 108 | MP0004947_skin_inflammation | 1.03222298 |
| 109 | MP0005620_abnormal_muscle_contractility | 1.02183837 |
| 110 | MP0003633_abnormal_nervous_system | 1.00970052 |
| 111 | MP0004087_abnormal_muscle_fiber | 1.00001386 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.99455919 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.98750308 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.98729240 |
| 115 | MP0006138_congestive_heart_failure | 0.98135542 |
| 116 | MP0005621_abnormal_cell_physiology | 0.97018658 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.95396383 |
| 118 | MP0000747_muscle_weakness | 0.94114446 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.93313100 |
| 120 | MP0000534_abnormal_ureter_morphology | 0.91690794 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.91313713 |
| 122 | MP0001664_abnormal_digestion | 0.90075123 |
| 123 | MP0000759_abnormal_skeletal_muscle | 0.89232122 |
| 124 | MP0005409_darkened_coat_color | 0.88816083 |
| 125 | MP0008872_abnormal_physiological_respon | 0.88190889 |
| 126 | MP0005535_abnormal_body_temperature | 0.87968091 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.86730239 |
| 128 | MP0002269_muscular_atrophy | 0.86570332 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.86298456 |
| 130 | MP0001299_abnormal_eye_distance/ | 0.85545894 |
| 131 | MP0006072_abnormal_retinal_apoptosis | 0.85373685 |
| 132 | MP0005501_abnormal_skin_physiology | 0.85285502 |
| 133 | MP0001614_abnormal_blood_vessel | 0.83434738 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.83402898 |
| 135 | MP0001270_distended_abdomen | 0.83138506 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.82876616 |
| 137 | MP0009053_abnormal_anal_canal | 0.82687836 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.82553375 |
| 139 | MP0002925_abnormal_cardiovascular_devel | 0.81888076 |
| 140 | MP0001905_abnormal_dopamine_level | 0.81604670 |
| 141 | MP0003690_abnormal_glial_cell | 0.81378601 |
| 142 | MP0002152_abnormal_brain_morphology | 0.80649653 |
| 143 | MP0001986_abnormal_taste_sensitivity | 0.80529267 |
| 144 | MP0002229_neurodegeneration | 0.80431367 |
| 145 | MP0002090_abnormal_vision | 0.80337319 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.80290843 |
| 147 | MP0003631_nervous_system_phenotype | 0.79536839 |
| 148 | MP0002933_joint_inflammation | 0.79373646 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.79170379 |
| 150 | MP0000678_abnormal_parathyroid_gland | 0.78385123 |
| 151 | MP0000750_abnormal_muscle_regeneration | 0.77023478 |
| 152 | MP0000428_abnormal_craniofacial_morphol | 0.76954715 |
| 153 | MP0002972_abnormal_cardiac_muscle | 0.76657721 |
| 154 | MP0002078_abnormal_glucose_homeostasis | 0.75999519 |
| 155 | MP0005448_abnormal_energy_balance | 0.75837242 |
| 156 | MP0003634_abnormal_glial_cell | 0.75832266 |
| 157 | MP0002009_preneoplasia | 0.75685465 |
| 158 | MP0002796_impaired_skin_barrier | 0.74192931 |
| 159 | MP0000604_amyloidosis | 0.73741715 |
| 160 | MP0003172_abnormal_lysosome_physiology | 0.73570949 |
| 161 | MP0003303_peritoneal_inflammation | 0.73568767 |
| 162 | MP0005394_taste/olfaction_phenotype | 0.73462845 |
| 163 | MP0005499_abnormal_olfactory_system | 0.73462845 |
| 164 | MP0004510_myositis | 0.73374075 |
| 165 | MP0000467_abnormal_esophagus_morphology | 0.72472424 |
| 166 | MP0002653_abnormal_ependyma_morphology | 0.70662316 |
| 167 | MP0002928_abnormal_bile_duct | 0.70115042 |
| 168 | MP0000762_abnormal_tongue_morphology | 0.69315221 |
| 169 | MP0002092_abnormal_eye_morphology | 0.67956823 |
| 170 | MP0002116_abnormal_craniofacial_bone | 0.67315534 |
| 171 | MP0001175_abnormal_lung_morphology | 0.67256400 |
| 172 | MP0002128_abnormal_blood_circulation | 0.64247899 |
| 173 | MP0002086_abnormal_extraembryonic_tissu | 0.63931451 |
| 174 | MP0001533_abnormal_skeleton_physiology | 0.63893043 |
| 175 | MP0002113_abnormal_skeleton_development | 0.63502496 |
| 176 | MP0000681_abnormal_thyroid_gland | 0.63427519 |
| 177 | MP0009672_abnormal_birth_weight | 0.63389884 |
| 178 | MP0005390_skeleton_phenotype | 0.62993061 |
| 179 | MP0003828_pulmonary_edema | 0.62710256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.32362100 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.19079111 |
| 3 | Epileptic encephalopathy (HP:0200134) | 4.18501770 |
| 4 | Focal motor seizures (HP:0011153) | 3.97151051 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.86486033 |
| 6 | Ankle clonus (HP:0011448) | 3.82159736 |
| 7 | Pheochromocytoma (HP:0002666) | 3.71605567 |
| 8 | Visual hallucinations (HP:0002367) | 3.53439991 |
| 9 | Myokymia (HP:0002411) | 3.50528073 |
| 10 | Hyperacusis (HP:0010780) | 3.44377310 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.34508270 |
| 12 | Hyperventilation (HP:0002883) | 3.24753723 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.19792023 |
| 14 | Cerebral aneurysm (HP:0004944) | 3.09026259 |
| 15 | Cervical subluxation (HP:0003308) | 3.02526375 |
| 16 | Oligomenorrhea (HP:0000876) | 2.99017896 |
| 17 | Atonic seizures (HP:0010819) | 2.97853147 |
| 18 | Febrile seizures (HP:0002373) | 2.93301908 |
| 19 | Broad face (HP:0000283) | 2.91862823 |
| 20 | Depression (HP:0000716) | 2.91698254 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.89126259 |
| 22 | Shallow orbits (HP:0000586) | 2.77771293 |
| 23 | Flat acetabular roof (HP:0003180) | 2.72847384 |
| 24 | Focal seizures (HP:0007359) | 2.71780309 |
| 25 | Vertebral compression fractures (HP:0002953) | 2.68528452 |
| 26 | Distal lower limb amyotrophy (HP:0008944) | 2.63811422 |
| 27 | Gait imbalance (HP:0002141) | 2.63564598 |
| 28 | Menstrual irregularities (HP:0000858) | 2.63423059 |
| 29 | Ulnar bowing (HP:0003031) | 2.61866230 |
| 30 | Poor suck (HP:0002033) | 2.61821578 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 2.57190761 |
| 32 | Arterial tortuosity (HP:0005116) | 2.56895626 |
| 33 | Obstructive sleep apnea (HP:0002870) | 2.54240988 |
| 34 | Myotonia (HP:0002486) | 2.52315620 |
| 35 | Agitation (HP:0000713) | 2.50902488 |
| 36 | Absence seizures (HP:0002121) | 2.49735399 |
| 37 | Vascular tortuosity (HP:0004948) | 2.49535472 |
| 38 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47247612 |
| 39 | EEG with generalized epileptiform discharges (HP:0011198) | 2.47174743 |
| 40 | Lower limb muscle weakness (HP:0007340) | 2.45773575 |
| 41 | Ketoacidosis (HP:0001993) | 2.44693995 |
| 42 | Increased connective tissue (HP:0009025) | 2.43673879 |
| 43 | Asymmetry of the thorax (HP:0001555) | 2.43447442 |
| 44 | Hepatocellular necrosis (HP:0001404) | 2.43178214 |
| 45 | Fetal akinesia sequence (HP:0001989) | 2.39009384 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 2.38868678 |
| 47 | Bladder diverticulum (HP:0000015) | 2.38747149 |
| 48 | Hypercortisolism (HP:0001578) | 2.37986686 |
| 49 | Exercise-induced muscle cramps (HP:0003710) | 2.36154317 |
| 50 | Spinal canal stenosis (HP:0003416) | 2.33390500 |
| 51 | Hypsarrhythmia (HP:0002521) | 2.33280098 |
| 52 | Broad-based gait (HP:0002136) | 2.32165457 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 2.31558470 |
| 54 | Atrophic scars (HP:0001075) | 2.31451891 |
| 55 | Short nail (HP:0001799) | 2.31017392 |
| 56 | Mitral regurgitation (HP:0001653) | 2.30357187 |
| 57 | Polyphagia (HP:0002591) | 2.29000619 |
| 58 | Urinary urgency (HP:0000012) | 2.28477241 |
| 59 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.28435290 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.27965494 |
| 61 | Abnormal hair whorl (HP:0010721) | 2.27248754 |
| 62 | Long toe (HP:0010511) | 2.26403332 |
| 63 | Distal upper limb amyotrophy (HP:0007149) | 2.25899839 |
| 64 | Upper limb amyotrophy (HP:0009129) | 2.25899839 |
| 65 | Truncal ataxia (HP:0002078) | 2.25773847 |
| 66 | Wormian bones (HP:0002645) | 2.25043443 |
| 67 | Thin bony cortex (HP:0002753) | 2.25015059 |
| 68 | Congenital primary aphakia (HP:0007707) | 2.24795486 |
| 69 | Aneurysm (HP:0002617) | 2.24501146 |
| 70 | Generalized tonic-clonic seizures (HP:0002069) | 2.23285624 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.22781233 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.22586406 |
| 73 | Spastic gait (HP:0002064) | 2.22433169 |
| 74 | Aortic dissection (HP:0002647) | 2.21877575 |
| 75 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21192143 |
| 76 | Aortic aneurysm (HP:0004942) | 2.20917536 |
| 77 | Spinal rigidity (HP:0003306) | 2.20407233 |
| 78 | Disproportionate tall stature (HP:0001519) | 2.20068890 |
| 79 | Anxiety (HP:0000739) | 2.19824388 |
| 80 | Myoglobinuria (HP:0002913) | 2.19259819 |
| 81 | Blue sclerae (HP:0000592) | 2.18187869 |
| 82 | Ankle contracture (HP:0006466) | 2.14645887 |
| 83 | Fragile skin (HP:0001030) | 2.14127814 |
| 84 | Insomnia (HP:0100785) | 2.13426740 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 2.12906227 |
| 86 | Narrow nasal bridge (HP:0000446) | 2.11796179 |
| 87 | Biconcave vertebral bodies (HP:0004586) | 2.11065320 |
| 88 | Blue irides (HP:0000635) | 2.09213732 |
| 89 | Growth hormone excess (HP:0000845) | 2.09144401 |
| 90 | Postural instability (HP:0002172) | 2.09020674 |
| 91 | Left ventricular hypertrophy (HP:0001712) | 2.08902948 |
| 92 | Broad metatarsal (HP:0001783) | 2.08618085 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 2.07554762 |
| 94 | Central scotoma (HP:0000603) | 2.06470678 |
| 95 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06427132 |
| 96 | Calf muscle hypertrophy (HP:0008981) | 2.06423726 |
| 97 | Progressive inability to walk (HP:0002505) | 2.06263167 |
| 98 | Ventricular fibrillation (HP:0001663) | 2.05848143 |
| 99 | Deep venous thrombosis (HP:0002625) | 2.05791785 |
| 100 | Abnormality of the lower motor neuron (HP:0002366) | 2.04721144 |
| 101 | Limb-girdle muscle atrophy (HP:0003797) | 2.03626612 |
| 102 | Athetosis (HP:0002305) | 2.02682980 |
| 103 | Failure to thrive in infancy (HP:0001531) | 2.02679610 |
| 104 | Prolonged QT interval (HP:0001657) | 2.02654370 |
| 105 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.02233036 |
| 106 | Impaired pain sensation (HP:0007328) | 2.02172799 |
| 107 | Abnormality of pain sensation (HP:0010832) | 2.02172799 |
| 108 | Abnormality of the calf musculature (HP:0001430) | 2.02113333 |
| 109 | Increased variability in muscle fiber diameter (HP:0003557) | 2.01086334 |
| 110 | Hypoventilation (HP:0002791) | 2.00766558 |
| 111 | Difficulty climbing stairs (HP:0003551) | 2.00201029 |
| 112 | Hepatic necrosis (HP:0002605) | 1.99428908 |
| 113 | Achilles tendon contracture (HP:0001771) | 1.99305329 |
| 114 | Hypothermia (HP:0002045) | 1.99088162 |
| 115 | Cholecystitis (HP:0001082) | 1.98918006 |
| 116 | Abnormal gallbladder physiology (HP:0012438) | 1.98918006 |
| 117 | Hypoplasia of the brainstem (HP:0002365) | 1.98239389 |
| 118 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98239389 |
| 119 | Hemorrhage of the eye (HP:0011885) | 1.98092052 |
| 120 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97285710 |
| 121 | Drooling (HP:0002307) | 1.96104807 |
| 122 | Excessive salivation (HP:0003781) | 1.96104807 |
| 123 | Hemiplegia (HP:0002301) | 1.95162660 |
| 124 | Lower limb amyotrophy (HP:0007210) | 1.94667540 |
| 125 | Poor eye contact (HP:0000817) | 1.94406182 |
| 126 | Dysmetric saccades (HP:0000641) | 1.94185021 |
| 127 | Turricephaly (HP:0000262) | 1.93961838 |
| 128 | Mitral valve prolapse (HP:0001634) | 1.93648209 |
| 129 | Lissencephaly (HP:0001339) | 1.93480139 |
| 130 | Dysdiadochokinesis (HP:0002075) | 1.92868299 |
| 131 | Torticollis (HP:0000473) | 1.92799423 |
| 132 | Advanced eruption of teeth (HP:0006288) | 1.92738060 |
| 133 | Peritonitis (HP:0002586) | 1.92695342 |
| 134 | Genu recurvatum (HP:0002816) | 1.91017764 |
| 135 | Dialeptic seizures (HP:0011146) | 1.89179941 |
| 136 | Joint laxity (HP:0001388) | 1.89162379 |
| 137 | Emotional lability (HP:0000712) | 1.87609972 |
| 138 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87602366 |
| 139 | Long palpebral fissure (HP:0000637) | 1.87326687 |
| 140 | Distal lower limb muscle weakness (HP:0009053) | 1.86691447 |
| 141 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86638327 |
| 142 | Neurofibrillary tangles (HP:0002185) | 1.85597344 |
| 143 | Hand muscle atrophy (HP:0009130) | 1.85381165 |
| 144 | Bronchomalacia (HP:0002780) | 1.85106258 |
| 145 | EMG: myopathic abnormalities (HP:0003458) | 1.84628326 |
| 146 | Rimmed vacuoles (HP:0003805) | 1.84307014 |
| 147 | Pointed chin (HP:0000307) | 1.83600677 |
| 148 | Abnormal social behavior (HP:0012433) | 1.83224714 |
| 149 | Impaired social interactions (HP:0000735) | 1.83224714 |
| 150 | Sudden death (HP:0001699) | 1.83160675 |
| 151 | Dislocated radial head (HP:0003083) | 1.82641934 |
| 152 | Natal tooth (HP:0000695) | 1.82559367 |
| 153 | Abnormal ossification of hand bones (HP:0005921) | 1.82230534 |
| 154 | Spinal cord lesions (HP:0100561) | 1.81622273 |
| 155 | Syringomyelia (HP:0003396) | 1.81622273 |
| 156 | Sleep apnea (HP:0010535) | 1.81535329 |
| 157 | Neonatal short-limb short stature (HP:0008921) | 1.81347707 |
| 158 | Abnormality of the Achilles tendon (HP:0005109) | 1.81244325 |
| 159 | Muscle stiffness (HP:0003552) | 1.80780793 |
| 160 | Hemiparesis (HP:0001269) | 1.80744364 |
| 161 | Impaired vibratory sensation (HP:0002495) | 1.80624900 |
| 162 | Focal dystonia (HP:0004373) | 1.80041164 |
| 163 | Psychosis (HP:0000709) | 1.79472231 |
| 164 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.78889910 |
| 165 | Precocious puberty (HP:0000826) | 1.78038954 |
| 166 | Mitral stenosis (HP:0001718) | 1.77926669 |
| 167 | Abnormality of dentin (HP:0010299) | 1.76836997 |
| 168 | Neoplasm of the heart (HP:0100544) | 1.74957306 |
| 169 | Craniofacial dystonia (HP:0012179) | 1.74852941 |
| 170 | Lymphangioma (HP:0100764) | 1.74744803 |
| 171 | Dysostosis multiplex (HP:0000943) | 1.73224692 |
| 172 | Mucopolysacchariduria (HP:0008155) | 1.71944770 |
| 173 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71944770 |
| 174 | Abnormality of the radial head (HP:0003995) | 1.71689906 |
| 175 | Metaphyseal cupping (HP:0003021) | 1.70797375 |
| 176 | Abnormality of the thoracic spine (HP:0100711) | 1.69926525 |
| 177 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69594878 |
| 178 | Abnormality of carpal bone ossification (HP:0006257) | 1.68511706 |
| 179 | Stridor (HP:0010307) | 1.68086641 |
| 180 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.67650881 |
| 181 | Osteolytic defects of the hand bones (HP:0009699) | 1.67650881 |
| 182 | Hyperextensible skin (HP:0000974) | 1.64894140 |
| 183 | Vertebral arch anomaly (HP:0008438) | 1.64636774 |
| 184 | Patellar dislocation (HP:0002999) | 1.64437779 |
| 185 | Abnormality of the acetabulum (HP:0003170) | 1.64162638 |
| 186 | Coxa vara (HP:0002812) | 1.60483746 |
| 187 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.59315826 |
| 188 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.59315826 |
| 189 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.59315826 |
| 190 | Bowel diverticulosis (HP:0005222) | 1.58379644 |
| 191 | Back pain (HP:0003418) | 1.57769562 |
| 192 | Broad palm (HP:0001169) | 1.57686551 |
| 193 | Hammertoe (HP:0001765) | 1.55785117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.99168506 |
| 2 | ICK | 3.12077147 |
| 3 | MAP3K4 | 2.85287885 |
| 4 | PHKG2 | 2.69868593 |
| 5 | PHKG1 | 2.69868593 |
| 6 | RIPK1 | 2.64485910 |
| 7 | SMG1 | 2.49966553 |
| 8 | NTRK3 | 2.48494794 |
| 9 | PRPF4B | 2.42754016 |
| 10 | DAPK2 | 2.39614684 |
| 11 | PDGFRA | 2.38957241 |
| 12 | MAP2K7 | 2.38719385 |
| 13 | MARK1 | 2.38027821 |
| 14 | CDK12 | 2.22052949 |
| 15 | MAP3K12 | 2.13492500 |
| 16 | EPHA2 | 2.02197385 |
| 17 | PRKD3 | 1.99147209 |
| 18 | MAPK13 | 1.94958084 |
| 19 | EPHB1 | 1.88898358 |
| 20 | MINK1 | 1.83633145 |
| 21 | CDK19 | 1.75026700 |
| 22 | TRIB3 | 1.71343702 |
| 23 | SGK223 | 1.65151479 |
| 24 | SGK494 | 1.65151479 |
| 25 | PDK3 | 1.61292263 |
| 26 | PDK4 | 1.61292263 |
| 27 | SGK2 | 1.53094974 |
| 28 | PTK2 | 1.52219479 |
| 29 | MAP2K3 | 1.51072495 |
| 30 | LMTK2 | 1.50403798 |
| 31 | MAP3K9 | 1.43874230 |
| 32 | MARK2 | 1.43304659 |
| 33 | SIK2 | 1.39000942 |
| 34 | DAPK1 | 1.37476928 |
| 35 | MAP2K4 | 1.37162314 |
| 36 | AKT3 | 1.36164684 |
| 37 | MTOR | 1.28657292 |
| 38 | PRKD2 | 1.28047938 |
| 39 | PTK2B | 1.26365705 |
| 40 | SGK3 | 1.25666630 |
| 41 | CAMKK1 | 1.23827764 |
| 42 | CAMKK2 | 1.23730074 |
| 43 | PTK6 | 1.22236684 |
| 44 | RPS6KA2 | 1.21431843 |
| 45 | CDK5 | 1.21093235 |
| 46 | CCNB1 | 1.20275455 |
| 47 | IRAK3 | 1.20074634 |
| 48 | MAP3K6 | 1.19832581 |
| 49 | PAK6 | 1.18470853 |
| 50 | NTRK2 | 1.17125323 |
| 51 | EPHA4 | 1.16516949 |
| 52 | EEF2K | 1.15336562 |
| 53 | PRKCH | 1.10976338 |
| 54 | MAP3K10 | 1.10562788 |
| 55 | PAK4 | 1.10181686 |
| 56 | MST1R | 1.09450381 |
| 57 | BRAF | 1.09126227 |
| 58 | TTN | 1.08888547 |
| 59 | STK38 | 1.08063344 |
| 60 | KSR1 | 1.05516886 |
| 61 | DYRK1B | 1.03263043 |
| 62 | TYRO3 | 1.01905421 |
| 63 | CDK8 | 1.01423143 |
| 64 | MET | 1.01412430 |
| 65 | DDR2 | 1.00849573 |
| 66 | LATS2 | 1.00673376 |
| 67 | PRKCG | 1.00114627 |
| 68 | EPHA3 | 0.99302012 |
| 69 | ARAF | 0.98123500 |
| 70 | TNIK | 0.97757613 |
| 71 | FGFR3 | 0.96921940 |
| 72 | MAP3K3 | 0.96535551 |
| 73 | NME1 | 0.95215574 |
| 74 | CAMK1D | 0.93667338 |
| 75 | PKN2 | 0.93043893 |
| 76 | PAK3 | 0.92097093 |
| 77 | SCYL2 | 0.91245459 |
| 78 | EPHB2 | 0.87626807 |
| 79 | ZAP70 | 0.87607080 |
| 80 | TSSK6 | 0.87578978 |
| 81 | SIK3 | 0.87404496 |
| 82 | PDGFRB | 0.86253743 |
| 83 | ERBB3 | 0.83471113 |
| 84 | CDK18 | 0.81318949 |
| 85 | PLK2 | 0.81300290 |
| 86 | RPS6KL1 | 0.76857863 |
| 87 | RPS6KC1 | 0.76857863 |
| 88 | PINK1 | 0.74806732 |
| 89 | CDK15 | 0.74652874 |
| 90 | PDPK1 | 0.73209753 |
| 91 | GRK5 | 0.72034856 |
| 92 | CDK6 | 0.71576009 |
| 93 | MAPKAPK5 | 0.70739210 |
| 94 | CDK14 | 0.69818026 |
| 95 | NEK1 | 0.69382801 |
| 96 | MAP3K11 | 0.68787086 |
| 97 | CDK11A | 0.68557441 |
| 98 | BMX | 0.68556064 |
| 99 | MAPK12 | 0.67148882 |
| 100 | KSR2 | 0.67092422 |
| 101 | WNK3 | 0.66964741 |
| 102 | ROCK1 | 0.65131349 |
| 103 | PAK2 | 0.64851151 |
| 104 | DMPK | 0.63517035 |
| 105 | MAP3K7 | 0.62338686 |
| 106 | RET | 0.62315244 |
| 107 | FER | 0.62065351 |
| 108 | PDK2 | 0.61868366 |
| 109 | MAP3K1 | 0.61555483 |
| 110 | ILK | 0.61223270 |
| 111 | CAMK1G | 0.60824357 |
| 112 | TYK2 | 0.60741608 |
| 113 | CAMK2A | 0.60473101 |
| 114 | DAPK3 | 0.59660362 |
| 115 | HIPK2 | 0.59392712 |
| 116 | JAK1 | 0.58739391 |
| 117 | CAMK1 | 0.58422846 |
| 118 | NEK9 | 0.57458140 |
| 119 | UHMK1 | 0.57044252 |
| 120 | TESK2 | 0.56804898 |
| 121 | BCKDK | 0.56543366 |
| 122 | MAP2K1 | 0.56500924 |
| 123 | DYRK1A | 0.54703491 |
| 124 | MAP3K13 | 0.54674284 |
| 125 | TBK1 | 0.54032956 |
| 126 | FES | 0.53547620 |
| 127 | MYLK | 0.52657539 |
| 128 | MAP3K2 | 0.52545699 |
| 129 | ERN1 | 0.52202842 |
| 130 | SIK1 | 0.52093008 |
| 131 | MAP2K6 | 0.52087647 |
| 132 | RPS6KA6 | 0.50987915 |
| 133 | CAMK2G | 0.50909811 |
| 134 | TESK1 | 0.50115547 |
| 135 | LRRK2 | 0.48382296 |
| 136 | TAOK1 | 0.48217356 |
| 137 | NTRK1 | 0.47910473 |
| 138 | ROCK2 | 0.47584394 |
| 139 | CAMK2B | 0.46839410 |
| 140 | ADRBK1 | 0.46738917 |
| 141 | LATS1 | 0.45159549 |
| 142 | FGFR4 | 0.44844717 |
| 143 | CDC42BPA | 0.44110758 |
| 144 | MAPK11 | 0.43836145 |
| 145 | CAMK2D | 0.43706363 |
| 146 | PRKCE | 0.43603480 |
| 147 | OBSCN | 0.43092792 |
| 148 | BRSK1 | 0.42699794 |
| 149 | TAOK2 | 0.42695389 |
| 150 | PRKCZ | 0.42121633 |
| 151 | CDK9 | 0.41407513 |
| 152 | PRKD1 | 0.40147675 |
| 153 | BRD4 | 0.38690387 |
| 154 | JAK3 | 0.37162620 |
| 155 | PDK1 | 0.35861068 |
| 156 | LIMK1 | 0.34727897 |
| 157 | SRC | 0.32940613 |
| 158 | CDK4 | 0.32680435 |
| 159 | PIM2 | 0.32172876 |
| 160 | CDK7 | 0.32125467 |
| 161 | PRKAA1 | 0.30235446 |
| 162 | MAPK10 | 0.29994622 |
| 163 | CAMK4 | 0.29709207 |
| 164 | ERBB2 | 0.29301995 |
| 165 | GRK6 | 0.29171408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.76169760 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.70881984 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.55979148 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.55838501 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.21666234 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.18982461 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14900471 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.14847998 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.14136225 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.11724979 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.05695349 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.01991307 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.95417886 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.94055340 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.84874006 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.82842518 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80932265 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.78785315 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.78277531 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64680080 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.63243246 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.59871969 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59458162 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58100805 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53850565 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.52449573 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.52101567 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.48853805 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48333122 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47938484 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47881246 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47188170 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.46809167 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.46427452 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44866208 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44287625 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42295155 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41608642 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38974548 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.37334735 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.36460379 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36362322 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34994514 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32447908 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29676740 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26750779 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.26206088 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25309077 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.24945219 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23057739 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.23016950 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.22228480 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 1.20703250 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 1.20628578 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18245049 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16966141 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16394029 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 1.15941470 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15490317 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 1.14472160 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13636940 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 1.13545638 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.12896579 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 1.11719585 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11565259 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10783506 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06854605 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05661676 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05157953 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05139000 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03772657 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02422267 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02070170 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.01896695 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01381694 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99554627 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99056549 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97448459 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.97161591 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97064118 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.95288288 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94142139 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90535151 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90294548 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.90029064 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88788740 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86399433 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.86331506 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85136048 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83679002 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82466770 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82301326 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.82187933 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81909373 |
| 95 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81899843 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81768001 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81675021 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80821951 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80541582 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80171267 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79789605 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.78973558 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.78707407 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77724317 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76994898 |
| 106 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75843143 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73936256 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72406721 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71848504 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.71299096 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69679054 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69360355 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69155566 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.69070610 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68981774 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.68354030 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.68200592 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67362734 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67239531 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.67028409 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65909597 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65850462 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64643695 |
| 124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63188352 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.62939672 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62893013 |
| 127 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60213652 |
| 128 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59921051 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59049316 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.58738370 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56715505 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56413939 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55883071 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.55595449 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53244404 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53057758 |
| 137 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51662848 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51122621 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50540541 |
| 140 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49206258 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48755603 |
| 142 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48199265 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47126430 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.46776681 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45780679 |
| 146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44013768 |
| 147 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43672225 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43137766 |
| 149 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41332342 |
| 150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41106561 |
| 151 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40374463 |
| 152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40344851 |
| 153 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39084658 |
| 154 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37800119 |
| 155 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37241002 |
| 156 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36670267 |
| 157 | Phagosome_Homo sapiens_hsa04145 | 0.35276610 |
| 158 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34085687 |
| 159 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33472777 |
| 160 | Alcoholism_Homo sapiens_hsa05034 | 0.32808275 |
| 161 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31475385 |
| 162 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31282333 |

